Polycystic ovary syndrome (PCOS) affects up to 10% of women of reproductive age. It's a metabolic and hormonal disorder that causes irregular periods, excess androgens (male hormones), weight gain, and often difficulty getting pregnant.
At its core, PCOS is often driven by insulin resistance—which is exactly what GLP-1 medications address.
Why GLP-1s Make Sense for PCOS
GLP-1 medications attack PCOS from multiple angles:
- Improved insulin sensitivity: Breaking the cycle that drives androgen excess
- Weight loss: Even 5-10% weight loss can restore ovulation in many women with PCOS
- Direct effects on ovaries: GLP-1 receptors are present in ovarian tissue
- Reduced inflammation: Which contributes to hormonal dysfunction
What the Research Shows
Studies of GLP-1 medications in women with PCOS have found encouraging results:
- Significant reductions in testosterone and other androgens
- More regular menstrual cycles and restored ovulation
- Reduced hirsutism (excess hair growth) over time
- Improved fertility markers
- Better metabolic profiles (lipids, blood pressure)
Benefits Beyond Weight Loss
Real-World Reports
Beyond clinical trials, many women with PCOS share their experiences online:
- "My periods came back after 8 years of being irregular"
- "Lost 40 pounds and my testosterone normalized"
- "My acne cleared up within 3 months"
- "Got pregnant after 2 years of trying—had to stop the medication but it got my body ready"
These are anecdotes, not clinical data—but they align with what the research suggests.
GLP-1s vs. Metformin for PCOS
Metformin has long been prescribed off-label for PCOS. How do GLP-1s compare?
- Weight loss: GLP-1s produce significantly more weight loss than metformin
- Insulin sensitivity: Both improve it, GLP-1s may be more potent
- GI side effects: Both cause them initially, but metformin's persist longer for some
- Cost: Metformin is much cheaper; GLP-1s are expensive without insurance
- Evidence base: Metformin has decades of PCOS-specific data; GLP-1 research is newer but growing
Many clinicians now consider GLP-1s for PCOS patients who haven't responded adequately to metformin, or who need significant weight loss.
- Studies on semaglutide and tirzepatide in PCOS populations.
- American College of Obstetricians and Gynecologists. PCOS Guidelines.
- Endocrine Society Clinical Practice Guidelines.
- FDA Prescribing Information: Pregnancy and breastfeeding sections.